Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Foreign Blend
  • Asset Class: Equity
  • Geographic Focus: International

Investec Global Strategy Fund Ltd - Global Equity Fund

+ Add to Watchlist

INGEQAD:LX

299.24 USD 3.65 1.21%

As of 00:59:30 ET on 04/30/2015.

Snapshot for Investec Global Strategy Fund Ltd - Global Equity Fund (INGEQAD)

Year To Date: +6.75% 3-Month: +8.26% 3-Year: +11.23% 52-Week Range: 264.51 - 304.45
1-Month: +3.22% 1-Year: +6.45% 5-Year: +8.83% Beta vs NDUEACWF: 1.03

Mutual Fund Chart for INGEQAD

No chart data available.
  • INGEQAD:LX 299.24
  • 1M
  • 1Y
Interactive INGEQAD Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for INGEQAD

Investec Global Strategy Fund Limited - Global Equity Fund is an open-end fund incorporated in Luxembourg. The Fund's objective is capital growth by primarily investing in shares of companies on a global basis. 90% of the equity content must be listed on an exchange.

Inception Date: 06-24-2005 Telephone: -
Managers: -
Web Site: www.investecassetmanagement.com

Fundamentals for INGEQAD

NAV (on 2015-04-30) 299.24
Assets (M) (on 2015-04-30) 1,099.39
Fund Leveraged N
Minimum Investment 3,000.00
Minimum Subsequent Investment 750.00

Dividends for INGEQAD

No dividends reported

Fees & Expenses for INGEQAD

Front Load 5.00
Back Load 0.00
Current Mgmt Fee 2.00
Redemption Fee 0.00
12b1 Fee -
Expense Ratio -

Top Fund Holdings for INGEQAD

Filing Date: 02/28/2015
Name Position Value % of Total
Pfizer Inc 478,495 16,421,948 1.514%
Microsoft Corp 370,033 16,225,947 1.495%
Novartis AG 153,971 15,827,504 1.459%
Nestle SA 180,584 14,172,415 1.306%
PepsiCo Inc 135,234 13,385,461 1.234%
Anheuser-Busch InBev NV 102,272 13,042,912 1.202%
Cisco Systems Inc 441,839 13,038,669 1.202%
Citigroup Inc 238,514 12,502,904 1.152%
UnitedHealth Group Inc 108,402 12,317,719 1.135%
Shire PLC 147,077 11,989,695 1.105%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil